Literature DB >> 32995913

Time interval between (chemo)radiotherapy and subsequent laryngectomy is not prognostic for post operative complications and survival.

Thomas F Pézier1, Johannes A Rijken2, Bernard M Tijink2, W Weibel Braunius2, Remco de Bree2.   

Abstract

PURPOSE: Pharyngocutaneous fistula (PCF) formation and swallowing difficulties are common and troublesome complications following total laryngectomy (TL). Prior (chemo)radiotherapy ((C)RT) is thought to be a risk factor for these complications, but there is conflicting evidence as to whether the time interval between (C)RT and TL is important. The impact of time interval on these complications and also its impact on overall survival are investigated.
METHODS: This is a retrospective case note review of all patients undergoing TL at the University Medical Center, Utrecht, The Netherlands over the 10-year period from January 2008 to December 2017. The cohort was split into those who underwent TL within a year of finishing (C)RT and those longer than 1 year.
RESULTS: One hundred and twenty-six patients (108 males, 18 females), with a mean age of 66 underwent total laryngectomy after prior (C)RT in the study period. Overall 5-year survival was 35% with a median follow-up of 30 months. Fifty-four patients underwent laryngectomy within a year of their (C)RT versus 72 patients who had a time interval of more than one year. No differences in PCF rate, risk of dilatation or overall survival could be found between the two groups.
CONCLUSIONS: In this modern cohort, time interval between (C)RT and surgery did not impact PCF rate, risk of dilatation or overall survival.

Entities:  

Keywords:  Chemoradiation; Laryngeal cancer; Pharyngo-cutaneous fistula; Radiotherapy; Total laryngectomy

Year:  2020        PMID: 32995913     DOI: 10.1007/s00405-020-06384-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  3 in total

1.  Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

Authors:  David G Pfister; Sharon Spencer; David Adelstein; Douglas Adkins; Yoshimi Anzai; David M Brizel; Justine Y Bruce; Paul M Busse; Jimmy J Caudell; Anthony J Cmelak; A Dimitrios Colevas; David W Eisele; Moon Fenton; Robert L Foote; Thomas Galloway; Maura L Gillison; Robert I Haddad; Wesley L Hicks; Ying J Hitchcock; Antonio Jimeno; Debra Leizman; Ellie Maghami; Loren K Mell; Bharat B Mittal; Harlan A Pinto; John A Ridge; James W Rocco; Cristina P Rodriguez; Jatin P Shah; Randal S Weber; Gregory Weinstein; Matthew Witek; Frank Worden; Sue S Yom; Weining Zhen; Jennifer L Burns; Susan D Darlow
Journal:  J Natl Compr Canc Netw       Date:  2020-07       Impact factor: 11.908

Review 2.  Vascular irradiation damage: its cellular basis and likely consequences.

Authors:  J W Hopewell; D Campling; W Calvo; H S Reinhold; J H Wilkinson; T K Yeung
Journal:  Br J Cancer Suppl       Date:  1986

3.  How to study optimal timing of PET/CT for monitoring of cancer treatment.

Authors:  Werner Vach; Poul Flemming Høilund-Carlsen; Barbara Malene Fischer; Oke Gerke; Wolfgang Weber
Journal:  Am J Nucl Med Mol Imaging       Date:  2011-07-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.